We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 630

Bayer agrees to pay federal government $97.5 million to settle allegations of paying kickbacks to diabetes supplies companies

  • Locke Lord LLP
  • -
  • USA
  • -
  • December 3 2008

Last week Bayer HealthCare LLC (Bayer) agreed to pay $97.5 million plus interest to the federal government to settle allegations that Bayer paid kickbacks to diabetes supplies companies and caused such companies to submit false claims to Medicare

Illinois federal court: FDA premarket approval process preempts state law causes of action

  • Locke Lord LLP
  • -
  • USA
  • -
  • December 9 2008

Relying on the Supreme Court’s decision in Riegel, the U.S. District Court for the Northern District of Illinois recently held that the Food and Drug Administration’s (“FDA”) extensive premarket approval (“PMA”) process for Class III medical devices preempts state law causes of action for injuries allegedly caused by those devices

Wyeth vows to appeal $99 million punitive damages “aberration” in Nevada hormone replacement case

  • Locke Lord LLP
  • -
  • USA
  • -
  • October 23 2007

In the wake of a Nevada jury’s recent $99 million punitive damages judgment against Wyeth Pharmaceuticals Inc., in L. Brocklin v. Wyeth, No. CV04-01701 (October, 15, 2007), Wyeth’s attorneys are vowing to appeal what they are calling an “aberration” in the various hormone replacement cases brought against the Madison, N.J.-based company

Merck to pay $4.85 billion in landmark pharmaceutical settlement

  • Locke Lord LLP
  • -
  • USA
  • -
  • November 16 2007

In one of the largest civil settlements in U.S. history, Merck & Co., the New Jersey-based manufacturer of the anti-inflammatory drug Vioxx, recently agreed to pay $4.85 billion to end various Vioxx-related claims in which plaintiffs suffered a heart attack, sudden cardiac death, or stroke

UnitedHealthcare settles claims for $12 million

  • Locke Lord LLP
  • -
  • USA
  • -
  • October 23 2007

UnitedHealthcare, a subsidiary of UnitedHealth Group, Inc., entered into a settlement agreement last month whereby it agreed to pay $12 million to the Attorneys General of 36 states and the District of Columbia

Medtronic sued after recall of defibrillator leads

  • Locke Lord LLP
  • -
  • USA
  • -
  • November 27 2007

Minneapolis-based medical technology company Medtronic, Inc. was recently sued in federal court shortly after announcing a global recall of defibrillator leads

Illinois medical malpractice cap ruled unconstitutional

  • Locke Lord LLP
  • -
  • USA
  • -
  • December 4 2007

An Illinois judge recently struck down the two-year-old state law that capped medical malpractice awards, ruling that the law violates the Illinois constitution’s “separation of powers” clause by depriving judges and juries of their right to determine fair compensation

Supreme Court hears arguments in FDA preemption case

  • Locke Lord LLP
  • -
  • USA
  • -
  • December 5 2007

On Tuesday, December 4, the U.S. Supreme Court heard oral arguments in Riegel v. Medtronic, Inc

Mental health parity legislation

  • Locke Lord LLP
  • -
  • USA
  • -
  • November 27 2007

Earlier this year, bipartisan sponsors in the Ohio legislature introduced H.B. 170 (Coverage for Autism), which would require health plans to cover autism treatment

Pennsylvania state court vacates $3 million hormone replacement jury verdict based upon failure to prove causation

  • Locke Lord LLP
  • -
  • USA
  • -
  • December 14 2007

Pennsylvania trial court recently overturned a $3 million jury verdict in Philadelphia's first hormone replacement therapy trial